Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for stage III and IVa head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 4, 2011, Pages 1081-1088

  Maguire, Patrick D ^a   Papagikos, Michael ^a   Hamann, Sue ^a   Neal, Charles ^a   Meyerson, Martin ^a   Hayes, Neil ^b   Ungaro, Peter ^a   Kotz, Kenneth ^a   Couch, Marion ^b   Pollock, Hoke ^a   Tepper, Joel ^b  

^a NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Chemoradiation; Head and neck cancer; Hyperfractionation; IMRT

Indexed keywords

CHEMORADIATION; CIS-PLATIN; CONCURRENT CISPLATIN; HEAD AND NECK; HEAD-AND-NECK CANCER; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; HYPERFRACTIONATION; IMRT; INTENSITY MODULATED RADIATION THERAPY; LOCOREGIONAL CONTROL; LOW DOSE; MUCOSITIS; OVERALL SURVIVAL; PHASE II; PRE-TREATMENT; QUALITY OF LIFE; RADIATION THERAPY; RISK PLANNING;

DESIGN; DISEASES; PLATINUM COMPOUNDS; RADIOTHERAPY; TOXICITY;

PHYSICAL THERAPY;

CISPLATIN; CREATINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELLULITIS; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONSTIPATION; CREATININE BLOOD LEVEL; DEHYDRATION; DERMATITIS; DYSARTHRIA; DYSPHAGIA; FATIGUE; FEMALE; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; HYPERFRACTIONATED INTENSITY MODULATED RADIATION THERAPY; HYPOKALEMIA; HYPOPHARYNX CARCINOMA; INFECTION; LARYNX CARCINOMA; LEUKOPENIA; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; SIDE EFFECT; THROMBOSIS; TREATMENT PLANNING; UPPER GASTROINTESTINAL BLEEDING; VOICE CHANGE; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 79951953273     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.12.046     Document Type: Article

References (38)

1. T.G. Wendt, G.G. Grabenbauer, and C.M. Rodel Simultaneous radiochemotherapy vs. radiotherapy alone in advanced head and neck cancer: A randomized multicenter study J Clin Oncol 16 1998 1318 1324 (Pubitemid 28175746)
2. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy vs. concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma J Natl Cancer Inst 24 1999 2081 2086 (Pubitemid 30019568)
3. D.J. Adelstein, P. Lavertu, and J.P. Saxton Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck Cancer 88 2000 876 883 (Pubitemid 30091108)
4. F. Denis, P. Garaud, and E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant chemoradiotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76 (Pubitemid 41095116)
5. S. El-Sayed, and N. Nelson Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials J Clin Oncol 14 1996 838 847 (Pubitemid 26085529)
6. J.P. Pignon, J. Bourhis, and L. Designe Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of up-dated individual data Lancet 355 2000 949 955 (Pubitemid 30148259)
7. J.C. Horiot, R. LeFur, and T. Nguyen Hyperfractionation vs. conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231 241 (Pubitemid 23000765)
8. J.C. Horiot, P. Bontemps, and W. Van Den Bogaert Accelerated fractionation compared to conventional fractionation improves locoregional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111 121 (Pubitemid 27345198)
9. K.K. Fu, T.F. Pajak, and A. Trotti A RTOG phase III study to compare hyperfractionation and two variants fo accelerated fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16 (Pubitemid 30488207)
10. D.M. Brizel, M.E. Albers, and S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1803
11. P.D. Maguire, M.B. Meyerson, and C.R. Neal Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVa head and neck cancer in the community Int J Radiat Oncol Biol Phys 58 2004 698 704 (Pubitemid 38221124)
12. D. Johnson, L. Casey, and B. Noriega A pilot study of patient quality of life during radiation therapy treatment Qual Life Res 3 1994 267 272 (Pubitemid 24301634)
13. A. Trotti, D.J. Johnson, and C. Gwede Development of a head and neck companion module for the Quality of Life-Radiation Therapy Instrument (QOL-RTI) Int J Radiat Oncol Biol Phys 42 1998 257 261 (Pubitemid 28502770)
14. T. Murry, R. Madasu, and A. Martin Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer Head Neck 20 1998 31 37 (Pubitemid 27528300)
15. D.L. Ronis, S.A. Duffy, and K.E. Foler Changes in quality of life over year 1 in patients with head and neck cancer Arch Otol Head Neck Surg 134 2008 241 248 (Pubitemid 351439249)
16. P. Dirix, S. Nuyts, and V. Vander Poorten The influence of xerostomia after radiotherapy on quality of life: Results of a questionnaire in head and neck cancer Supp Care Control 16 2008 171 179
17. J.A. Langendijk, P. Doornaert, and I.M. Verdonck-deLeeuw Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 2008 3770 3776
18. S. Jabbari, H.M. Kim, and M. Feng Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report Int J Radiat Oncol Biol Phys 63 2005 725 731 (Pubitemid 41400058)
19. M. Yao, L.H. Karnell, and G.F. Funk Health-related quality of life outcomes following IMRT vs. conventional radiotherapy for oropharyngeal squamous cell carcinomas Int J Radiat Oncol Biol Phys 69 2007 1354 1360 (Pubitemid 350116394)
20. M.R. Vergeer, P.A. Doornaert, and D.H. Rietveld Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: Results of a nonrandomized prospective study using a standardized follow-up program Int J Radiat Oncol Biol Phys 74 2009 1 8
21. C.M. van Rij, W.D. Oughlane-Heemsbergen, and A.H. Ackerstaff Parotid-gland sparing IMRT for head and neck cancer improves xerostomia related quality of life Radiat Oncol 9 2008 3 4
22. E.H. Pow, D.L. Kwong, and A.S. McMillan Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial Int J Radiat Oncol Biol Phys 66 2006 981 991 (Pubitemid 44633504)
23. A. Lin, H.M. Kim, and J.E. Terrell Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study Int J Radiat Oncol Biol Phys 57 2003 61 70 (Pubitemid 36959739)
24. A. Eisbruch, P.C. Levendag, and F.Y. Feng Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences Int J Radiat Oncol Biol Phys 69 Suppl. 2007 S40 S42
25. M. Al-Sarraf, M. LeBlanc, and P.S. Giri Chemoradiotherapy vs. radiotherapy in patients with advanced nasopharyngeal cancer: A phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317 (Pubitemid 28175745)
26. K.K. Ang, J. Harris, and A.S. Garden Concomitant boost radiation plus concurrent cisplatin for advanced had and neck carcinomas: Radiation Therapy Oncology Group phase II trial 99-14 J Clin Oncol 23 2005 3008 3015 (Pubitemid 46224121)
27. A.S. Garden, J. Harris, and A. Trotti Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: A phase II trial of the Radiation Therapy Oncology Group (RTOG 99-14) Int J Radiat Oncol Biol Phys 71 2008 1351 1355 (Pubitemid 351978166)
28. S. Nuyts, P. Dirix, and P.M. Clement Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head and neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 73 2009 1088 1095
29. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153 (Pubitemid 29177873)
30. H.M. Keys, B.N. Bundy, and F.B. Stehman Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161 (Pubitemid 29177874)
31. G.K. Beckmann, F. Hoppe, and L. Pfreunder Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer Head Neck 27 2005 36 43 (Pubitemid 40024087)
32. A. Eisbruch, R.K. Ten Haken, and H.M. Kim Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer Int J Radiat Oncol Biol Phys 45 1999 77 87
33. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphasia: Early dose-effect relationships for the swallowing structures Int J Radiat Oncol Biol Phys 68 Suppl 2007 1289 1298 (Pubitemid 47176817)
34. H.B. Caglar, R.B. Tishler, and M. Othus Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 15 2008 1110 1118
35. P. Dirix, S. Abbeel, and B. Vanstraelen Dysphagia after chemoradiotherapy for head-and neck squamous cell carcinoma: Dose-effect relationships for the swallowing structures Int J Radiat Oncol Biol Phys 75 2009 385 392
36. J.J. Caudell, P.E. Schaner, and R.A. Desmond Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 73 2009 410 415
37. B. Jeremic, B. Milicic, and A. Dagovic Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, non-metastatic suamous cell carcinoma of the head and neck J Clin Oncol 22 2004 3540 3548 (Pubitemid 41103660)
38. P. Huguenin, K.T. Beer, and A. Allal Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy J Clin Oncol 22 2004 4665 4673